WeightWatchers
WeightWatchers Retools with AI, Dietitians and ZeroPoint Potatoes
WeightWatchers is making potatoes OK again as the storied weight management company leans into compounded GLP-1s, AI and B2B.
The Business of GLP-1s: Inside the New Weight Loss Drug Ecosystem
As GLP-1 drugs surge, here's how telehealth companies and brick-and-mortar fitness giants are responding to the Ozempic era.
WeightWatchers CEO Exits
Sima Sistani is out as CEO of WeightWatchers after leading the weight loss company for two years. Tara Comonte will serve as interim CEO.
Jenny Craig Returns as Digital-Only Service After Acquisition by Wellful
Jenny Craig, the famed weight loss and nutrition company, filed for Chapter 7 bankruptcy in May after four decades in business.
Wegovy Maker Sues Wellness Clinics, Spas Over Counterfeit Weight-Loss Drugs
Novo Nordisk has filed lawsuits against wellness clinics and spas for selling non-FDA-approved versions of its weight-loss drugs.
The Rise of Weight-Loss Medications: Are Diet Companies Doomed?
While body positivity was popular in recent years, the pendulum seems to have swung the other way with the rise of weight-loss medications.
Shrinking Waists, Sizable Earnings: Weight-Loss Drug Market Estimated at $100 Billion by 2030
According to Barclays, the weight-loss drug industry could even climb as high as $200 billion within the next decade.
How BODi is Flipping the Script on the ‘Imperfection Economy’
Carl Daikeler, co-founder and CEO of BODi, formerly Beachbody, explains why the company is changing its entire approach to fitness.
WeightWatchers’ Stock Surges After Obesity Drug Deal
WeightWatchers has acquired Sequence, a telehealth provider that gives users access to diabetes and weight loss drugs.
